Cognition Therapeutics, Inc. (CGTX) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CGTX Hot Sheet
Join SI Premium – FREE
Cognition Therapeutics, Inc. (NASDAQ: CGTX) reported Q1 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Cognition Therapeutics, Inc. (CGTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Golden Spike Resources plans name change, share consolidation and C$500K raise
- Rocket Lab joins U.S. Space Force's $981M NITE-STAR contract
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
